JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 28, 2005; DOI: 10.1124/jpet.105.084780


0022-3565/05/3142-693-702$20.00
JPET 314:693-702, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084780v1
314/2/693    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Grevenynghe, J.
Right arrow Articles by Fardel, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Grevenynghe, J.
Right arrow Articles by Fardel, O.

TOXICOLOGY

Human CD34-Positive Hematopoietic Stem Cells Constitute Targets for Carcinogenic Polycyclic Aromatic Hydrocarbons

J. van Grevenynghe, M. Bernard, S. Langouet, C. Le Berre, T. Fest, and O. Fardel

Institut National de la Santé et de la Recherche Médicale U620, Faculté de Pharmacie, Rennes, France (J.v.G., S.L., O.F.); Etablissement Français du Sang, Rennes, France (C.L.B.); and Service d'Hématologie Clinique (M.B.) and Laboratoire d'Hématologie-Immunologie (T.F., O.F.), Hôpital Pontchaillou–Centre Hospitalier Universitaire, Rennes, France

Polycyclic aromatic hydrocarbons (PAHs) are major carcinogenic environmental contaminants known to exert bone marrow toxicity and to induce leukemias, suggesting that these chemicals target hematopoietic stem cells. To investigate this hypothesis, we studied the effects of PAHs on cell proliferation and differentiation in human hematopoietic CD34+ cell cultures. Benzo(a)pyrene (BP), a prototypical PAH, was shown to markedly impair CD34+ cell expansion and to inhibit CD34+ cell differentiation into various hematological cell lineages, including erythroid, granulomacrophagic, and megakaryocytic lineages. This was associated with the induction of a caspase- and mitochondrion-related apoptosis process. CD34+ progenitor cells were found to exhibit functional expression of the aryl hydrocarbon receptor (AhR), and the use of the pure AhR antagonist 3'-methoxy-4'-nitroflavone partially counteracted the deleterious effects of BP in CD34+ cell cultures, underlining the involvement of AhR in BP toxicity. Additional events such as CYP1A1/1B1-dependent PAH metabolism and adduct formation were also required since 1) 2,3,7,8-tetrachlorodibenzo-p-dioxin, a very potent ligand of the AhR that is poorly metabolized and therefore does not generate reactive metabolites in contrast to PAHs, failed to affect CD34+ cell expansion; 2) the CYP1A1/1B1 inhibitor {alpha}-naphthoflavone blocked both BP adduct formation and BP toxicity; and 3) benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide, a highly reactive BP metabolite, exerted a marked toxicity toward CD34+ cell cultures. Overall, these data indicate that human hematopoietic CD34+ cells can bioactivate chemical carcinogens such as PAHs and, in this way, constitute targets for such carcinogenic environmental contaminants.


Received for publication February 9, 2005
Accepted April 26, 2005.

Address correspondence to: Dr. Olivier Fardel, INSERM U620, Faculté de Pharmacie, 2 avenue du Pr. Léon Bernard, 35043 Rennes, France. E-mail: olivier.fardel{at}univ-rennes1.fr




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. Seaman, A. Jumaan, E. Yanni, B. Lewis, J. Neyer, P. Roda, M. Xu, and R. Hoffman
Use of Molecular Testing to Identify a Cluster of Patients with Polycythemia Vera in Eastern Pennsylvania
Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Sharma, A. Neekhra, A. L. Gramajo, J. Patil, M. Chwa, B. D. Kuppermann, and M. C. Kenney
Effects of Benzo(e)Pyrene, a Toxic Component of Cigarette Smoke, on Human Retinal Pigment Epithelial Cells In Vitro
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5111 - 5117.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. W. Garrett and T. A. Gasiewicz
The Aryl Hydrocarbon Receptor Agonist 2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Circadian Rhythms, Quiescence, and Expression of Clock Genes in Murine Hematopoietic Stem and Progenitor Cells
Mol. Pharmacol., June 1, 2006; 69(6): 2076 - 2083.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Aninat, A. Piton, D. Glaise, T. Le Charpentier, S. Langouet, F. Morel, C. Guguen-Guillouzo, and A. Guillouzo
EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
Drug Metab. Dispos., January 1, 2006; 34(1): 75 - 83.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.